Management of acute coronary syndromes

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 6, 2001, Pages 917-922

  Schulman, Steven P ^a   Fessler, Henry E ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DALTEPARIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; RETEPLASE; STREPTOKINASE; TENECTEPLASE; THIENO[2,3 B]PYRIDINE DERIVATIVE; TICLOPIDINE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR;

ANALGESIA; CLINICAL TRIAL; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0035883737     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.6.2101047     Document Type: Review

References (48)

1. Acute coronary syndromes: Unstable angina and non-Q-wave myocardial infarction
2. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology
3. Coronary arteriographic findings soon after non-Q-wave myocardial infarction
4. Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death
5. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction
6. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
7. ACC/AHA guidelines for the management of patients with acute myocardial infarction
8. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
9. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years
10. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
11. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction
12. A comparison of reteplase with alteplase for acute myocardial infarction
13. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial
14. Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction
15. Abciximab facilitates the rate and extent of thrombolysis
16. Trial of abciximab with and without low-dose reteplase for acute myocardial infarction
17. Comparison of primary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction
18. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction
19. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction
20. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial
21. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
22. A clinical trial of the angiotensin converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
23. Indications for ACE inhibitors in the early treatment of acute myocardial infarction
24. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
25. Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction: ISIS-1
26. A randomized trial of propranolol in patients with acute myocardial infarction
27. Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
28. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomized trial
29. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease
30. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial
31. TIMI 11B-ESSENCE meta-analysis
32. Current role of platelet GPIIb/IIIa inhibitors in acute coronary syndromes
33. Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes
34. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
35. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
36. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
37. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction
38. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
39. Invasive compared with noninvasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
40. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
41. Efects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study: A randomized controlled trial
42. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations
43. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: Results of the TIMI III registry ECG ancillary study
44. Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease
45. Cardiac troponin T levels for risk stratification in acute myocardial ischemia
46. Acute coronary syndromes in the GUSTO-IIb trial. Prognostic insights and impact of recurrent ischemia
47. The TIMI risk score for unstable angina/non-ST elevation MI